Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)

SHA:688321 Revenue

Shenzhen Chipscreen Biosciences had revenue of 297.28M CNY in the quarter ending September 30, 2026, with 11.11% growth. This brings the company's total for the last twelve months to 1.08B, up 26.49% year-over-year. In the year 2025, Shenzhen Chipscreen Biosciences had annual revenue of 910.06M with 38.32% growth. That makes Shenzhen Chipscreen Biosciences the 19,048th largest company in the world by revenue and 3,484th in China.

• Revenue (ttm): 1.08B
• Revenue Growth: +26.49%
• P/S Ratio: 8.84
• Revenue / Employee: 1.04M
• Employees: 1,031
• Market Cap: 9.09B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South China 274.58M 30.7%
• East China 251.65M 28.1%
• North China 122.55M 13.7%
• Southwest Region 110.68M 12.4%
• Central China 79.36M 8.9%
• Northwest 28.05M 3.1%
• Northeast China 26.31M 2.9%
• Other 2.65M 0.3%

Fiscal year ended Dec 31, 2025 See the full SHA:688321 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	910.06M	252.11M	38.32%
Dec 31, 2024	657.95M	134.24M	25.63%
Dec 31, 2023	523.71M	-6.23M	-1.18%
Dec 31, 2022	529.94M	99.49M	23.11%
Dec 31, 2021	430.45M	160.98M	59.74%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error